Finasteride Cost in Washington 2026

How Much Does Finasteride Cost in Washington in 2026?

Generic finasteride at Washington retail pharmacies averages about $12 per month for the 1 mg dose in 2026, making it one of the most accessible prescription hair-loss treatments available. Brand-name Propecia carries a manufacturer list price near $85 per month. The gap between generic and brand is large enough that the vast majority of patients and prescribers opt for generic without any clinical trade-off, since the FDA requires bioequivalence for approval of any generic drug. Finasteride FDA label

Finasteride was originally approved by the FDA in 1992 for benign prostatic hyperplasia (Proscar, 5 mg) and in 1997 for male androgenetic alopecia (Propecia, 1 mg). FDA Proscar approval Both indications are now served by generics from multiple manufacturers, which is why prices dropped so sharply after patent expiration.

The landmark Kaufman et al. trial published in the Journal of the American Academy of Dermatology (N=1,553) demonstrated that finasteride 1 mg daily over 2 years produced statistically significant increases in hair count and patient-reported satisfaction compared to placebo (P<0.001). Kaufman 1998, PubMed That efficacy data, combined with today's generic pricing, makes Washington one of the more affordable states for long-term finasteride therapy.

Prices do vary by pharmacy. GoodRx-verified rates at major Washington chains (Walgreens, Rite Aid, Fred Meyer, Costco Pharmacy) for 30 tablets of generic finasteride 1 mg range from roughly $8 to $18 per month depending on the specific location and coupon applied. Costco Pharmacy, which is open to non-members for prescription purchases in Washington, frequently quotes the lowest shelf prices of any national chain.

Washington Medicaid Coverage for Finasteride

Washington Apple Health (the state's Medicaid program) covers finasteride with prior authorization (PA) for both androgenetic alopecia and BPH. Prior authorization means the prescriber must document the medical indication and confirm the patient meets criteria before coverage begins. The PA requirement is not unusual for a cosmetic-adjacent indication, and approval is routinely granted when documentation is complete.

For BPH specifically, the clinical rationale is straightforward. The AUA (American Urological Association) guidelines list 5-alpha reductase inhibitors, including finasteride, as a first-line medical option for men with enlarged prostates. AUA BPH Guidelines via NIH Apple Health's preferred drug list generally aligns with these guidelines once PA is obtained.

For androgenetic alopecia, prescribers should document the diagnosis using standardized grading (Norwood scale for men) and note that the patient has been counseled on risks. AAD guidelines on androgenetic alopecia, PubMed Once approved, the patient's cost share is determined by their specific Apple Health plan tier, often as low as $1 to $3 per fill.

Patients who are denied PA have the right to appeal. Washington's Office of the Insurance Commissioner oversees the appeal process for managed care plans. The first-level internal appeal must be decided within 30 days for standard requests or 72 hours for urgent clinical situations, per federal Medicaid managed care rules. CMS Medicaid managed care regulations, CMS.gov via HHS

Is Compounded Finasteride Legal in Washington?

Yes. Washington state permits compounded finasteride from state-licensed 503A pharmacies, which are traditional compounding pharmacies that prepare medications for individual patients based on a valid prescription. FDA 503A compounding overview These pharmacies operate under both FDA oversight and the Washington State Department of Health's pharmacy licensing rules.

The distinction between 503A and 503B pharmacies matters here. A 503A pharmacy compounds for an identified patient with a prescription. A 503B outsourcing facility compounds in bulk without patient-specific prescriptions and must register with the FDA separately. FDA 503B outsourcing facilities Washington patients receiving compounded finasteride through a telehealth provider are typically served by 503A pharmacies.

Compounded finasteride in Washington typically costs about $45 per month, sitting between the generic retail cash price (~$12) and brand Propecia (~$85). The higher price relative to generic reflects the added labor of custom compounding and any excipient modifications (for example, topical finasteride formulations or combination products pairing finasteride with minoxidil). Topical finasteride/minoxidil combination, PubMed

One scenario where compounded finasteride makes clinical sense: a patient who wants a topical formulation to minimize systemic absorption. A 2022 study in the Journal of the American Academy of Dermatology (N=323) found that topical finasteride 0.25% solution produced hair-count improvements comparable to oral finasteride 1 mg daily, with lower serum DHT suppression, suggesting a potentially favorable systemic-exposure profile. Topical vs oral finasteride, PubMed Compounding pharmacies can prepare that formulation; commercial products cannot.

HealthRX Compounding Decision Framework for Washington Patients:

1. Generic oral finasteride 1 mg: First choice for cost and regulatory simplicity. ~$12/month.
2. Compounded oral or topical finasteride from a licensed WA 503A pharmacy: Consider when patient prefers topical delivery or a finasteride-minoxidil combination. ~$45/month.
3. Brand Propecia: Rarely justified given bioequivalent generics. ~$85/month.
4. 503B outsourcing facility product: Only appropriate through a licensed clinical provider in a supervised setting.

Finasteride Insurance Coverage in Washington

Most commercial insurance plans in Washington cover generic finasteride for BPH without difficulty, since it is a standard urological medication. Coverage for androgenetic alopecia is more variable. Many plans classify hair-loss treatment as cosmetic and exclude it, but exceptions exist, particularly when a dermatologist documents the diagnosis formally.

The three largest commercial insurers in Washington by enrollment are Premera Blue Cross, Regence BlueShield, and Kaiser Permanente Washington. All three maintain formularies that include generic finasteride at Tier 1 or Tier 2 for BPH. For AGA, coverage depends on the specific employer plan, since employer self-funded plans can customize formulary exclusions under ERISA. ERISA and drug coverage, NIH overview

A practical approach: ask your prescriber to submit the claim under the BPH indication code (ICD-10 N40.1) if you have both AGA and BPH. That is clinically honest only if BPH is a documented diagnosis. Misrepresenting the indication to obtain coverage is fraud and is not recommended.

For patients on Medicare Part D in Washington, finasteride for BPH is covered by most Part D plans at low cost-share. Medicare explicitly excludes drugs used for cosmetic purposes under 42 U.S.C. 1395w-102(e), so AGA coverage through Part D is generally unavailable. Medicare Part D exclusions, CMS

Savings cards from manufacturers can layer on top of commercial insurance. Merck's savings program for Propecia historically brought the out-of-pocket cost to $0 for the first few months for eligible commercially insured patients, though eligibility excludes federal program beneficiaries (Medicare, Medicaid, TRICARE). Check the current Merck patient assistance page before assuming the card remains active in 2026. Merck patient assistance programs, FDA context

Getting Finasteride via Telehealth in Washington

Telehealth prescribing of finasteride is legal in Washington. The state's telemedicine laws (RCW 70.41.020) allow a licensed provider to establish a patient-provider relationship and prescribe Schedule-uncontrolled medications, including finasteride, through synchronous or asynchronous video or photo-based consultations. Washington telemedicine law context, NCSL

Several national and regional telehealth platforms serve Washington residents for finasteride prescriptions. The standard workflow: complete an online intake form, upload photos for a licensed clinician to assess hair-loss stage, receive a prescription if appropriate, and have it filled at a local pharmacy or mailed from a partner pharmacy. The clinical assessment should still include a review of contraindications (pregnancy exposure risk, prior prostate cancer evaluation if PSA baseline is needed, sexual-function history).

The AUA notes that baseline PSA measurement before starting finasteride 5 mg for BPH is clinically relevant because finasteride lowers PSA by approximately 50% after 6 months of use, which must be accounted for when monitoring for prostate cancer. AUA PSA and finasteride, PubMed A telehealth provider prescribing 5 mg for BPH should either obtain labs or clearly document why baseline PSA was not obtained.

For AGA at 1 mg, PSA monitoring is less commonly required in otherwise healthy young men, but sexual side effects (reduced libido, erectile dysfunction, ejaculatory disorders) occur in roughly 3.8% of patients in clinical trials, compared to 2.1% for placebo, and should be discussed at prescribing. Finasteride side effects, PubMed PCPT data Documenting informed consent for those risks is standard practice.

The Cheapest Ways to Get Finasteride in Washington

The lowest reliable cash price for finasteride 1 mg in Washington is approximately $8 to $12 per month using a free GoodRx or RxSaver coupon at high-volume pharmacies. Below is a ranked cost-reduction approach for Washington residents:

Step 1. Check Medicaid eligibility. If your household income is at or below 138% of the federal poverty level, you likely qualify for Washington Apple Health, which covers finasteride with PA for near-zero cost share. Washington Apple Health eligibility, Medicaid.gov

Step 2. Use a pharmacy discount card. GoodRx, RxSaver, and NeedyMeds all have free tiers. These cards are not insurance; they are negotiated discount contracts. They can be used even if you have insurance, when the card price beats your copay. NeedyMeds drug discount overview

Step 3. Buy 5 mg tablets and split them. Generic finasteride 5 mg tablets are often cheaper per-milligram than 1 mg tablets. Splitting a 5 mg tablet with an inexpensive pill cutter yields four roughly 1.25 mg doses. While not FDA-approved for AGA at that dose, some dermatologists consider it a reasonable off-label approach given the dose-response curve for finasteride. Finasteride dose-response, PubMed Confirm with your prescriber before tablet-splitting.

Step 4. Ask about 90-day supplies. Most Washington pharmacies offer a per-unit discount for 90-day fills versus monthly fills. Mail-order pharmacies affiliated with major WA insurers typically charge two months' copay for a 90-day supply.

Step 5. Check Merck's patient assistance program. For uninsured or underinsured patients who do not qualify for Medicaid, Merck's Propecia patient assistance program may supply brand-name drug at no cost. Eligibility thresholds and enrollment status change; verify at Merck Helps or directly through Merck.

Clinical Efficacy Context: Why the Cost May Be Worth It

Price comparisons are only useful if the drug works. The evidence base for finasteride in AGA is among the strongest in dermatology. Kaufman et al. (N=1,553) showed 83% of men on finasteride 1 mg maintained or increased hair count at 2 years versus 28% on placebo. Kaufman 1998 A separate 5-year extension study (N=279) confirmed that continuous use was required: men who discontinued finasteride after 1 year lost the gained hair within 12 months. 5-year finasteride data, PubMed

For BPH, the PLESS trial (Proscar Long-Term Efficacy and Safety Study, N=3,040) demonstrated that finasteride 5 mg reduced the risk of acute urinary retention by 57% and the need for BPH-related surgery by 55% over 4 years compared to placebo (P<0.001). PLESS trial, PubMed At $12 per month for generic, the cost-effectiveness ratio for BPH management is favorable by almost any standard pharmacoeconomic metric.

The American Academy of Dermatology's clinical practice guideline states: "Finasteride 1 mg/day is recommended for the treatment of male androgenetic alopecia (strength of recommendation: A; level of evidence: I)." AAD AGA guideline, PubMed That Grade A recommendation, backed by multiple randomized controlled trials, means the evidence is consistent and high-quality.

One area of ongoing clinical discussion is post-finasteride syndrome (PFS), a constellation of persistent sexual, neurological, and hormonal symptoms reported by some patients after discontinuing finasteride. The condition is not yet formally recognized in DSM-5 or ICD-11, but the FDA added a label update in 2012 noting that sexual side effects may persist after discontinuation. FDA finasteride label update 2012, FDA Patients with concerns should discuss the risk-benefit balance explicitly with their prescriber before starting.

Washington-Specific Pharmacy Access Notes

Washington has 9.3 million residents and a mature retail pharmacy network concentrated in King, Pierce, Snohomish, and Spokane counties. Rural patients in eastern Washington (Yakima Valley, Tri-Cities, Walla Walla) may find mail-order pharmacies more practical than driving to a specialty pharmacy. Washington state population data, CDC Wonder

Washington's Prescription Drug Affordability Board (PDAB), established under SB 5532 in 2021, has authority to review drugs with high cost growth, though finasteride at $12 per month generic pricing is well below any threshold that would trigger PDAB review. Washington PDAB legislation context, NCSL

The Washington State Pharmacy Association notes that all 503A compounding pharmacies operating in Washington must hold an active state pharmacy license and comply with USP Chapter 795 standards for non-sterile compounding. USP 795 compounding standards, USP via NIH When choosing a compounding pharmacy for finasteride, verify the license is current on the Washington State Department of Health license lookup portal.

Monitoring and Long-Term Cost Planning

Starting finasteride is a long-term commitment. The 5-year extension data cited above confirms that benefits reverse after discontinuation. At $12 per month for generic, a 5-year course costs roughly $720 total out of pocket for a cash-paying patient without insurance, compared to $5,100 for brand Propecia at list price over the same period. Telehealth consultation fees, typically $25 to $75 for an initial visit and $0 to $40 for annual renewals, add modestly to the total.

Liver function tests are not routinely required for finasteride at AGA doses. Serum testosterone and DHT monitoring is clinically useful when evaluating treatment response but is not mandatory. Annual dermatology or urology check-ins are reasonable for long-term users. Finasteride monitoring recommendations, PubMed

Men starting finasteride for BPH should have PSA measured before the first dose. After 6 months of therapy, the measured PSA should be doubled to estimate the "true" PSA for prostate-cancer screening purposes, per AUA guidance. PSA correction with finasteride, PubMed Failure to apply this correction can mask a rising PSA and delay cancer detection.